Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Preliminary Efficacy of Bilateral Nucleus Accumbens-Targeted Low-Intensity Focused Ultrasound Neuromodulation Using ExAblate 4000 Type 2.1 in Patients With Stimulant Use Disorder: A Single-Center, Prospective, Single-Arm, Open-Label, Investigator-Initiated Feasibility Trial

NCT06474026 is registered in ClinicalTrials.gov with Korea University Anam Hospital as lead sponsor.

NCT NCT06474026
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06474026 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Preliminary Efficacy of Bilateral Nucleus Accumbens-Targeted Low-Intensity Focused Ultrasound Neuromodulation Using ExAblate 4000 Type 2.1 in Patients With Stimulant Use Disorder: A Single-Center, Prospective, Single-Arm, Open-Label, Investigator-Initiated Feasibility Trial
Lead sponsor
Korea University Anam Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
July 1, 2024
Completion date
July 31, 2027
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

psychostimulant use disorder(pud)